An interactive voice response diary for patients with Non-dystrophic myotonia

Muscle and Nerve

Volumn 44, Issue 1, 2011, Pages 30-35

  Statland, Jeffrey M ^a   Wang, Yunxia ^b   Richesson, Rachel ^c   Bundy, Brian ^c   Herbelin, Laura ^b   Gomes, Joe ^c   Trivedi, Jaya ^d   Venance, Shannon ^e   Amato, Anthony ^f   Hanna, Michael ^g   Griggs, Robert ^a   Barohn, Richard J ^b   Cannon, S C ^h   Hart, K ^h,h   Herr, B ^h   Fiahlo, D ^h   Matthews, E ^h   Salajegheh, M ^h   Walsh, R ^h   Hahn, A ^h   Cleland, J ^h   Krischer, J ^h   Donlan, M ^h   McLin, R ^h   Pandya, S ^h   Eichinger, K ^h   Findlater, K ^h   Dewar, P T L ^h   Whiteside, K ^h   Gorham, N ^h   Ladonna, K ^h   Verheyden, J ^h   Patterson, B ^h   Cuthbertson, D ^h   Lloyd, J ^h   more..

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h NONE

Author keywords

Ion channel gene defects; Muscle disease; Myotonia; Nondystrophic myotonia; Patient reported outcome measures

Indexed keywords

MEXILETINE;

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HAND GRIP; HUMAN; INTERACTIVE VOICE RESPONSE SYSTEM; MAJOR CLINICAL STUDY; MALE; MUSCLE FATIGUE; MYALGIA; MYOTONIC DYSTROPHY; NON DYSTROPHIC MYOTONIA; PRIORITY JOURNAL; RIGIDITY; SCORING SYSTEM; WARMING;

EID: 79959323897     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22007     Document Type: Article

References (21)

1. Cannon SC. Spectrum of sodium channel disturbances in the nondystrophic myotonias and periodic paralyses. Kidney Int 2000;57:772-779.
2. Colding-Jorgensen E. Phenotypic variability in myotonia congenita. Muscle Nerve 2005;32:19-34.
3. Ptacek L. The familial periodic paralyses and nondystrophic myotonias. Am J Med 1998;105:58-70.
4. Ptacek LJ, Johnson KJ, Griggs RC. Genetics and physiology of the myotonic muscle disorders. N Engl J Med 1993;328:482-489.
5. Fialho D, Schorge S, Pucovska U, Davies NP, Labrum R, Haworth A, et al. Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. Brain 2007;130:3265-3274.
6. Hoffman EP, Wang J. Duchenne-Becker muscular dystrophy and the nondystrophic myotonias. Paradigms for loss of function and change of function of gene products. Arch Neurol 1993;50:1227-1237.
7. Vicart S, Sternberg D, Fontaine B, Meola G. Human skeletal muscle sodium channelopathies. Neurol Sci 2005;26:194-202.
8. Matthews E, Tan SV, Fialho D, Sweeney MG, Sud R, Haworth R, et al. What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed. Neurology 2008;70:50-53.
9. Rudel R, Ricker K, Lehmann-Horn F. Genotype-phenotype correlations in human skeletal muscle sodium channel diseases. Arch Neurol 1993;50:1241-1248.
10. Meola G, Moxley RT III. Myotonic dystrophy type 2 and related myotonic disorders. J Neurol 2004;251:1173-1182.
11. Cleland JC, Griggs RC. Treatment of neuromuscular channelopathies: current concepts and future prospects. Neurotherapeutics 2008;5:607-612.
12. Trip J, Drost G, van Engelen BG, Faber CG. Drug treatment for myotonia. Cochrane Database Syst Rev 2006;Jan 25(1):CD004762.
13. Kwiecinski H, Ryniewicz B, Ostrzycki A. Treatment of myotonia with antiarrhythmic drugs. Acta Neurol Scand 1992;86:371-375.
14. Trip J, Drost G, Ginjaar HB, Niemen FH, van der Kooi AJ, de Visser M, et al. Redefining the clinical phenotypes of non-dystrophic myotonic syndromes. J Neurol Neurosurg Psychiatry 2009;80:647-652.
15. Chang CH. Patient-reported outcomes measurement and management with innovative methodologies and technologies. Qual Life Res 2007;16(suppl 1):157-166.
16. Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health 2008;11:322-333.
17. Palmblad M, Tiplady B. Electronic diaries and questionnaires: designing user interfaces that are easy for all patients to use. Qual Life Res 2004;13:1199-207.
18. Stone AA, Schiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient non-compliance with paper diaries. BMJ 2002;324:1193-1194.
19. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006;4:79.
20. Moxley RT III, Logigian EL, Martens WB, Annis CL, Pandya S, Moxley RT IV, et al. Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1). Muscle Nerve 2007;36:320-328.
21. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-974.